References
Advani, S. M., P. G. Advani, H. M. VonVille and S. H. Jafri (2018). ”Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials.” BMC Cancer 18 (1): 1174.
Baracos, V. E., L. Martin, M. Korc, D. C. Guttridge and K. C. H. Fearon (2018). ”Cancer-associated cachexia.” Nature Reviews Disease Primers 4 (1): 17105.
Bhattarai, K. R., M. Chaudhary, H.-R. Kim and H.-J. Chae (2020). ”Endoplasmic Reticulum (ER) Stress Response Failure in Diseases.”Trends in Cell Biology 30 (9): 672-675.
Biswas, A. K. and S. Acharyya (2020). ”Cancer-Associated Cachexia: A Systemic Consequence of Cancer Progression.” Annual Review of Cancer Biology 4 (1): 391-411.
Brown, J. L., D. E. Lee, M. E. Rosa-Caldwell, L. A. Brown, R. A. Perry, W. S. Haynie, K. Huseman, K. Sataranatarajan, H. Van Remmen, T. A. Washington, M. P. Wiggs and N. P. Greene (2018). ”Protein imbalance in the development of skeletal muscle wasting in tumour-bearing mice.”J Cachexia Sarcopenia Muscle 9 (5): 987-1002.
Chitti, S. V., T. Kang, P. Fonseka, A. L. Marzan, S. Stewart, S. Shahi, K. Bramich, C.-S. Ang, M. Pathan, S. Gummadi and S. Mathivanan (2023). ”Proteomic analysis of the small extracellular vesicles and soluble secretory proteins from cachexia inducing and non-inducing cancer cells.” PROTEOMICS n/a (n/a): 2100314.
Deval, C., S. Mordier, C. Obled, D. Bechet, L. Combaret, D. Attaix and M. Ferrara (2001). ”Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting.”Biochem J 360 (Pt 1): 143-150.
Doyle, A., G. Zhang, E. A. Abdel Fattah, N. T. Eissa and Y. P. Li (2011). ”Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways.” Faseb j 25 (1): 99-110.
Fearon, K., J. Arends and V. Baracos (2013). ”Understanding the mechanisms and treatment options in cancer cachexia.” Nat Rev Clin Oncol 10 (2): 90-99.
Fearon, K., F. Strasser, S. D. Anker, I. Bosaeus, E. Bruera, R. L. Fainsinger, A. Jatoi, C. Loprinzi, N. MacDonald, G. Mantovani, M. Davis, M. Muscaritoli, F. Ottery, L. Radbruch, P. Ravasco, D. Walsh, A. Wilcock, S. Kaasa and V. E. Baracos (2011). ”Definition and classification of cancer cachexia: an international consensus.”Lancet Oncol 12 (5): 489-495.
Gallot, Y. S. and K. R. Bohnert (2021) ”Confounding Roles of ER Stress and the Unfolded Protein Response in Skeletal Muscle Atrophy.”International Journal of Molecular Sciences 22 DOI: 10.3390/ijms22052567.
Greiwe, J., B. Cheng, D. Rubin, K. Yarasheski and C. Semenkovich (2001). ”Resistance exercise decreases skeletal muscle tumor necrosis factor ?? in frail elderly humans.” FASEB journal : official publication of the Federation of American Societies for Experimental Biology15 : 475-482.
Guttridge, D. C., M. W. Mayo, L. V. Madrid, C. Y. Wang and A. S. Baldwin, Jr. (2000). ”NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia.” Science289 (5488): 2363-2366.
Halle, J. L., G. S. Pena, H. G. Paez, A. J. Castro, H. B. Rossiter, N. P. Visavadiya, M. A. Whitehurst and A. V. Khamoui (2019). ”Tissue-specific dysregulation of mitochondrial respiratory capacity and coupling control in colon-26 tumor-induced cachexia.” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 317 (1): R68-R82.
Hinkelbein, J., L. Böhm, S. Braunecker, C. Adler, E. De Robertis and F. Cirillo (2017). ”Decreased Tissue COX5B Expression and Mitochondrial Dysfunction during Sepsis-Induced Kidney Injury in Rats.” Oxid Med Cell Longev 2017 : 8498510.
Huang, G., G. Ge, D. Wang, B. Gopalakrishnan, D. H. Butz, R. J. Colman, A. Nagy and D. S. Greenspan (2011). ”α3(V) collagen is critical for glucose homeostasis in mice due to effects in pancreatic islets and peripheral tissues.” J Clin Invest 121 (2): 769-783.
Ibebunjo, C., J. M. Chick, T. Kendall, J. K. Eash, C. Li, Y. Zhang, C. Vickers, Z. Wu, B. A. Clarke, J. Shi, J. Cruz, B. Fournier, S. Brachat, S. Gutzwiller, Q. Ma, J. Markovits, M. Broome, M. Steinkrauss, E. Skuba, J. R. Galarneau, S. P. Gygi and D. J. Glass (2013). ”Genomic and proteomic profiling reveals reduced mitochondrial function and disruption of the neuromuscular junction driving rat sarcopenia.”Mol Cell Biol 33 (2): 194-212.
Knoblauch, A., C. Will, G. Goncharenko, S. Ludwig and V. Wixler (2007). ”The binding of Mss4 to alpha-integrin subunits regulates matrix metalloproteinase activation and fibronectin remodeling.” Faseb j21 (2): 497-510.
Layne, M. D. and S. R. Farmer (1999). ”Tumor necrosis factor-alpha and basic fibroblast growth factor differentially inhibit the insulin-like growth factor-I induced expression of myogenin in C2C12 myoblasts.”Exp Cell Res 249 (1): 177-187.
Lecker, S. H., R. T. Jagoe, A. Gilbert, M. Gomes, V. Baracos, J. Bailey, S. R. Price, W. E. Mitch and A. L. Goldberg (2004). ”Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression.” Faseb j 18 (1): 39-51.
Li, H., S. Malhotra and A. Kumar (2008). ”Nuclear factor-kappa B signaling in skeletal muscle atrophy.” J Mol Med (Berl)86 (10): 1113-1126.
Li, Y. P., C. M. Atkins, J. D. Sweatt and M. B. Reid (1999). ”Mitochondria mediate tumor necrosis factor-alpha/NF-kappaB signaling in skeletal muscle myotubes.” Antioxid Redox Signal 1 (1): 97-104.
Li, Y. P. and M. B. Reid (2000). ”NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes.”Am J Physiol Regul Integr Comp Physiol 279 (4): R1165-1170.
Lim, S., J. L. Brown, T. A. Washington and N. P. Greene (2020). ”Development and progression of cancer cachexia: Perspectives from bench to bedside.” Sports Medicine and Health Science 2 (4): 177-185.
Mantovani, G., A. Macciò, C. Madeddu, L. Mura, E. Massa, M. C. Mudu, C. Mulas, M. R. Lusso, G. Gramignano and M. B. Piras (2001). ”Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites.”J Mol Med (Berl) 79 (7): 406-414.
Miller, S. G., P. S. Hafen, A. S. Law, C. B. Springer, D. L. Logsdon, T. M. O’Connell, C. A. Witczak and J. J. Brault (2021). ”AMP deamination is sufficient to replicate an atrophy-like metabolic phenotype in skeletal muscle.” Metabolism 123 : 154864.
Niida, Y., M. Masuda, Y. Adachi, A. Yoshizawa, H. Ohminami, Y. Mori, K. Ohnishi, H. Yamanaka-Okumura, T. Uchida, T. Nikawa, H. Yamamoto, M. Miyazaki and Y. Taketani (2020). ”Reduction of stearoyl-CoA desaturase (SCD) contributes muscle atrophy through the excess endoplasmic reticulum stress in chronic kidney disease.” J Clin Biochem Nutr67 (2): 179-187.
Nuoc, T.-N., S. Kim, S. H. Ahn, J.-S. Lee, B.-J. Park and T.-H. Lee (2017). ”The analysis of antioxidant expression during muscle atrophy induced by hindlimb suspension in mice.” The Journal of Physiological Sciences 67 (1): 121-129.
Pathan, M., S. Keerthikumar, C. S. Ang, L. Gangoda, C. Y. Quek, N. A. Williamson, D. Mouradov, O. M. Sieber, R. J. Simpson, A. Salim, A. Bacic, A. F. Hill, D. A. Stroud, M. T. Ryan, J. I. Agbinya, J. M. Mariadason, A. W. Burgess and S. Mathivanan (2015). ”FunRich: An open access standalone functional enrichment and interaction network analysis tool.” Proteomics 15 (15): 2597-2601.
Piñol-Jurado, P., E. Gallardo, N. de Luna, X. Suárez-Calvet, C. Sánchez-Riera, E. Fernández-Simón, C. Gomis, I. Illa and J. Díaz-Manera (2017). ”Platelet-Derived Growth Factor BB Influences Muscle Regeneration in Duchenne Muscle Dystrophy.” The American Journal of Pathology 187 (8): 1814-1827.
Roeland, E. J., K. Bohlke, V. E. Baracos, E. Bruera, E. Del Fabbro, S. Dixon, M. Fallon, J. Herrstedt, H. Lau, M. Platek, H. S. Rugo, H. H. Schnipper, T. J. Smith, W. Tan and C. L. Loprinzi (2020). ”Management of Cancer Cachexia: ASCO Guideline.” J Clin Oncol 38 (21): 2438-2453.
Sugg, K. B., M. A. Korn, D. C. Sarver, J. F. Markworth and C. L. Mendias (2017). ”Inhibition of platelet-derived growth factor signaling prevents muscle fiber growth during skeletal muscle hypertrophy.” FEBS Lett 591 (5): 801-809.
Suzuki, H., A. Asakawa, H. Amitani, N. Nakamura and A. Inui (2013). ”Cancer cachexia–pathophysiology and management.” J Gastroenterol 48 (5): 574-594.
Thoma, A. and A. P. Lightfoot (2018). ”NF-kB and Inflammatory Cytokine Signalling: Role in Skeletal Muscle Atrophy.” Adv Exp Med Biol1088 : 267-279.
Tisdale, M. J. (2009). ”Mechanisms of cancer cachexia.” Physiol Rev 89 (2): 381-410.
Tiwari, A., I. Schuiki, L. Zhang, E. M. Allister, M. B. Wheeler and A. Volchuk (2013). ”SDF2L1 interacts with the ER-associated degradation machinery and retards the degradation of mutant proinsulin in pancreatic β-cells.” J Cell Sci 126 (Pt 9): 1962-1968.
Uezumi, A., S. Fukada, N. Yamamoto, M. Ikemoto-Uezumi, M. Nakatani, M. Morita, A. Yamaguchi, H. Yamada, I. Nishino, Y. Hamada and K. Tsuchida (2014). ”Identification and characterization of PDGFRα+ mesenchymal progenitors in human skeletal muscle.” Cell Death Dis5 (4): e1186.
Vargas-Franco, D., R. Kalra, I. Draper, C. A. Pacak, A. Asakura and P. B. Kang (2022). ”The Notch signaling pathway in skeletal muscle health and disease.” Muscle & Nerve 66 (5): 530-544.
Vaz, R., G. G. Martins, S. Thorsteinsdóttir and G. Rodrigues (2012). ”Fibronectin promotes migration, alignment and fusion in an in vitro myoblast cell model.” Cell Tissue Res 348 (3): 569-578.
von Haehling, S. and S. D. Anker (2014). ”Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014.” J Cachexia Sarcopenia Muscle 5 (4): 261-263.
Wang, P. and I. H. Chaudry (1996). ”Mechanism of hepatocellular dysfunction during hyperdynamic sepsis.” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology270 (5): R927-R938.
Wang, Y. F., Z. Y. An, D. H. Lin and W. L. Jin (2022). ”Targeting cancer cachexia: Molecular mechanisms and clinical study.” MedComm (2020) 3 (4): e164.
Webster, J. M., L. Kempen, R. S. Hardy and R. C. J. Langen (2020). ”Inflammation and Skeletal Muscle Wasting During Cachexia.” Front Physiol 11 : 597675.
Williamson, D. L., S. R. Kimball and L. S. Jefferson (2005). ”Acute treatment with TNF-alpha attenuates insulin-stimulated protein synthesis in cultures of C2C12 myotubes through a MEK1-sensitive mechanism.”Am J Physiol Endocrinol Metab 289 (1): E95-104.
Winder, W. W., B. F. Holmes, D. S. Rubink, E. B. Jensen, M. Chen and J. O. Holloszy (2000). ”Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle.” J Appl Physiol (1985) 88 (6): 2219-2226.
Wolfe, R. R. (2006). ”The underappreciated role of muscle in health and disease2.” The American Journal of Clinical Nutrition84 (3): 475-482.
Wyart, E., L. B. Bindels, E. Mina, A. Menga, S. Stanga and P. E. Porporato (2020). ”Cachexia, a Systemic Disease beyond Muscle Atrophy.”Int J Mol Sci 21 (22).
Yadav, A., A. Dahuja and R. Dabur (2021). ”Dynamics of Toll-like Receptors Signaling in Skeletal Muscle Atrophy.” Curr Med Chem28 (28): 5831-5846.
Zhang, W., Y. Liu and H. Zhang (2021). ”Extracellular matrix: an important regulator of cell functions and skeletal muscle development.”Cell & Bioscience 11 (1): 65.